Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 1138-1142

  Aakre, Kristin M ^a   Thue, Geir ^b   Svarstad, Einar ^a,b   Skadberg, Oyvind ^c   Sandberg, Sverre ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Albuminuria; Creatinine; Glomerular filtration rate; Guideline adherence; Primary health care; Questionnaire

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DETERIORATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; LABORATORY TEST; MALE; PATIENT ASSESSMENT; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; URINALYSIS;

AGED; CHRONIC DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LABORATORIES; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 79954986845     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.03.004     Document Type: Article

References (35)

1. Coresh J., Astor B.C., Greene T., Eknoyan G., Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003, 41:1-12.
2. Hallan S.I., Coresh J., Astor B.C., Asberg A., Powe N.R., Romundstad S., et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006, 17:2275-2284.
3. Israni R.K., Shea J.A., Joffe M.M., Feldman H.I. Physician characteristics and knowledge of CKD management. Am J Kidney Dis 2009, 54:238-247.
4. Roderick P., Jones C., Tomson C., Mason J. Late referral for dialysis: improving the management of chronic renal disease. QJM 2002, 95:363-370.
5. John R., Webb M., Young A., Stevens P.E. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004, 43:825-835.
6. National Collaborating Centre for Chronic Conditions. Chronic kidney disease: national guideline for early identification and management in adults in primary and secondary care 2008, London (UK), Royal college of physicians.
7. Scottish Intercollegiate Guideline Network. Diagnosis and management of chronic kidney disease. (Accessed May 2009). http://www.sign.ac.uk/pdf/sign103.pdf.
8. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Part 4. Definition and classification of stages of chronic kidney disease. Guideline 1. Definition and stages of chronic kidney disease (Accessed May 2010). http://www.kidney.org/Professionals/Kdoqi/guidelines_ckd/p4_class_g1.htm.
9. Akbari A., Swedko P.J., Clark H.D., Hogg W., Lemelin J., Magner P., et al. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med 2004, 164:1788-1792.
10. Hemmelgarn B.R., Zhang J., Manns B.J., James M.T., Quinn R.R., Ravani P., et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA 2010, 303:1151-1158.
11. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Part 7. Stratification of risk for progression of kidney disease and development of cardiovascular disease. Guideline 13. Factors associated with loss of kidney function in chronic kidney disease. (Accessed May 2010). http://www.kidney.org/Professionals/Kdoqi/guidelines_ckd/p7_risk_g13.htm.
12. Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess; 14:1-184.
13. Halbesma N., Kuiken D.S., Brantsma A.H., Bakker S.J., Wetzels J.F., De Zeeuw D., et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 2006, 17:2582-2590.
14. Hallan S.I., Ritz E., Lydersen S., Romundstad S., Kvenild K., Orth S.R. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009, 20:1069-1077.
15. van der Velde M., Halbesma N., de Charro F.T., Bakker S.J., de Zeeuw D., de Jong P.E., et al. Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol 2009, 20:852-862.
16. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Guideline 5. Assessment of proteinuria. (Accessed May 2010). http://www.kidney.org/Professionals/Kdoqi/guidelines_ckd/p5_lab_g5.htm.
17. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Guideline 9: Pharmacologial therapy: nondiabetes kidney disease. (Accessed December 2010). http://www.kidney.org/professionals/KDOQI/guidelines_bp/guide_9.htm.
18. Rule A.D., Gussak H.M., Pond G.R., Bergstralh E.J., Stegall M.D., Cosio F.G., et al. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 2004, 43:112-119.
19. Hartmann A., Holdaas H., Os I., Hunderi O.H., Hallan S., Wideroe T.E., et al. Staging and measurement of renal function in chronic renal conditions. Tidsskr Nor Laegeforen 2006, 126:1198-1200.
20. Hartmann A., Jenssen T., Midtvedt K., Reisaeter A.V., Fauchald P., Henriksen T., et al. Protein-creatinine ratio-a simple method for proteinuria assessment in clinical practice. Tidsskr Nor Laegeforen 2002, 122:2180-2183.
21. Levey A.S., Coresh J., Greene T., Marsh J., Stevens L.A., Kusek J.W., et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772.
22. Fraser C.G., Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989, 27:409-437.
23. Holzel W.G. Intra-individual variation of some analytes in serum of patients with chronic renal failure. Clin Chem 1987, 33:670-673.
24. Sood R., Sood A., Ghosh A.K. Non-evidence-based variables affecting physicians' test-ordering tendencies: a systematic review. Neth J Med 2007, 65:167-177.
25. Hrisos S., Eccles M.P., Francis J.J., Dickinson H.O., Kaner E.F., Beyer F., et al. Are there valid proxy measures of clinical behaviour? A systematic review. Implement Sci 2009, 4:37.
26. Frazee L.A., Samandari S., Tanphaichitr N., Bourguet C.C., Pfister E.W. Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center. Am J Ther 2006, 13:18-23.
27. Kissmeyer L., Kong C., Cohen J., Unwin R.J., Woolfson R.G., Neild G.H. Community nephrology: audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transplant 1999, 14:2150-2155.
28. Harris S.B., Stewart M., Brown J.B., Wetmore S., Faulds C., Webster-Bogaert S., et al. Type 2 diabetes in family practice. Room for improvement. Can Fam Physician 2003, 49:778-785.
29. Aakre KM, Thue G, Subramaniam-Haavik S, et al. Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: a European survey in primary care. Diabetes Res Clin Pract; 89:103-109.
30. Cooper J.G., Claudi T., Jenum A.K., Thue G., Hausken M.F., Ingskog W., et al. Quality of care for patients with type 2 diabetes in primary care in Norway is improving: results of cross-sectional surveys of 33 general practices in 1995 and 2005. Diabetes Care 2009, 32:81-83.
31. Spranger C.B., Ries A.J., Berge C.A., Radford N.B., Victor R.G. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 2004, 117:14-18.
32. Wang Y.R., Alexander G.C., Stafford R.S. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007, 167:141-147.
33. Winearls C.G., Glassock R.J. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009, 75:1009-1014.
34. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet; 375:2073-2081.
35. Munkerud S. Decision-making in general practice-the effect of financial incentives on the use of laboratory analyses. HERO On line Working Paper Series Oslo University. Health Economics Research Programme 2008, 13.